Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12376889rdf:typepubmed:Citationlld:pubmed
pubmed-article:12376889lifeskim:mentionsumls-concept:C1140680lld:lifeskim
pubmed-article:12376889lifeskim:mentionsumls-concept:C0007765lld:lifeskim
pubmed-article:12376889lifeskim:mentionsumls-concept:C0029925lld:lifeskim
pubmed-article:12376889lifeskim:mentionsumls-concept:C0393534lld:lifeskim
pubmed-article:12376889lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:12376889lifeskim:mentionsumls-concept:C0597879lld:lifeskim
pubmed-article:12376889pubmed:issue10lld:pubmed
pubmed-article:12376889pubmed:dateCreated2002-10-11lld:pubmed
pubmed-article:12376889pubmed:abstractTextParaneoplastic cerebellar degeneration is a rare disorder caused likely by autoimmune mechanisms in malignant oncologic diseases, and the most common tumors are ovarian, breast, lung cancer, and m. Hodgkin. An immune reaction is supposed to be directed against identical antigens of cerebellum and tumor, and paraneoplastic antibodies called anti-Yo, anti-Hu, anti-Ri, or anti-Tr are often detected in blood and cerebrospinal fluid. The course of paraneoplastic cerebellar degeneration as a complication of ovarian cancer is described. The relationship between the malignancy and pathologic changes in cerebellum was confirmed by positive immunohistochemical and immunofluorescence reaction between a patient's anti-Yo-positive serum and her own Purkinje's and ovarian cancer cells.lld:pubmed
pubmed-article:12376889pubmed:languagegerlld:pubmed
pubmed-article:12376889pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12376889pubmed:citationSubsetIMlld:pubmed
pubmed-article:12376889pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12376889pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12376889pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12376889pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12376889pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12376889pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12376889pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12376889pubmed:statusMEDLINElld:pubmed
pubmed-article:12376889pubmed:monthOctlld:pubmed
pubmed-article:12376889pubmed:issn0028-2804lld:pubmed
pubmed-article:12376889pubmed:authorpubmed-author:BartonDDlld:pubmed
pubmed-article:12376889pubmed:authorpubmed-author:VelenskáZZlld:pubmed
pubmed-article:12376889pubmed:authorpubmed-author:StouracPPlld:pubmed
pubmed-article:12376889pubmed:authorpubmed-author:SejdováMMlld:pubmed
pubmed-article:12376889pubmed:authorpubmed-author:RusinaRRlld:pubmed
pubmed-article:12376889pubmed:issnTypePrintlld:pubmed
pubmed-article:12376889pubmed:volume73lld:pubmed
pubmed-article:12376889pubmed:ownerNLMlld:pubmed
pubmed-article:12376889pubmed:authorsCompleteYlld:pubmed
pubmed-article:12376889pubmed:pagination995-8lld:pubmed
pubmed-article:12376889pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:meshHeadingpubmed-meshheading:12376889...lld:pubmed
pubmed-article:12376889pubmed:year2002lld:pubmed
pubmed-article:12376889pubmed:articleTitle[Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].lld:pubmed
pubmed-article:12376889pubmed:affiliationNeurologische Klinik, 3. Medizinische Fakultät der Karlsuniversität und Fakultätskrankenhaus Královské Vinohrady, Prag, Switzerland. bartos@fnkv.czlld:pubmed
pubmed-article:12376889pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12376889pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:12376889pubmed:publicationTypeCase Reportslld:pubmed